People: Veracyte Inc (VCYT.OQ)
18 Apr 2019
Mr. Christopher M. Hall is no longer President, Chief Operating Officer of the Company, effective July 1, 2019. He served as our Chief Commercial Officer from March 2010 to September 2014. Prior to joining us, Mr. Hall served as Chief Business Officer of Celera Corporation, a diagnostics company focusing on personalized disease management, from October 2008 to February 2010. From August 2002 to February 2010, Mr. Hall served in various executive and senior positions at Berkeley HeartLab, Inc., a cardiovascular disease management company that was acquired by Celera in October 2007, including Chief Clinical Operations Officer and Vice President of Marketing. Mr. Hall holds a B.A. in Economics and Political Science from DePauw University and an M.B.A. from Harvard Business School.
|Total Annual Compensation, USD||415,000|
|Restricted Stock Awards, USD||181,000|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||488,004|
|Fiscal Year Total, USD||1,084,000|